Task 3.1Identification of lead nanobodies targeting CD8β, CD69 & CD163TypeCohort studyDesignParticipantsDurationnot available
Task 3.2Generation of bi-specific nanobodies targeting CD8β+/CD69+ activated cytotoxic T-lymphocytes (CTLs)TypeCohort studyDesignParticipantsDurationnot available
Task 3.3Development of a PET tracer against S100A9TypeCohort studyDesignParticipantsDurationnot available
Task 3.4Development of small peptide tracers for imaging PD-1 and PD-L1TypeCohort studyDesignParticipantsDurationnot available
Task 3.5Radiolabelling of subsets of immune cells for tracking immune cells in vivoTypeCohort studyDesignParticipantsDurationnot available
Task 3.6Nanobody labelling optimisation for PET and OITypeCohort studyDesignParticipantsDurationnot available
Task 3.7GMP production of a new tracer vehicleTypeCohort studyDesignParticipantsDurationnot available
Task 3.8GMP-compliant labelling of nanobodies, peptides, small molecules, minibodies and antibodiesTypeCohort studyDesignParticipantsDurationnot available
Task 4.1Determination of the ideal set of multi-modality molecular imaging for immune cell traffickingTypeCohort studyDesignParticipantsDurationnot available
Task 4.2Development and validation of imaging protocols for immunotracersTypeCohort studyDesignParticipantsDurationnot available